- Report
- March 2024
- 97 Pages
Middle East, Africa
From €1426EUR$1,500USD£1,198GBP
- Report
- October 2024
- 70 Pages
Latin America
From €903EUR$950USD£759GBP
- Report
- August 2023
- 664 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- February 2024
- 867 Pages
Global
From €5608EUR$5,899USD£4,711GBP
- Report
- February 2020
- 267 Pages
Global
From €4657EUR$4,899USD£3,913GBP
- Report
- January 2020
- 473 Pages
Global
From €4657EUR$4,899USD£3,913GBP
- Report
- October 2018
- 450 Pages
Global
From €3326EUR$3,499USD£2,794GBP
- Report
- March 2024
- 329 Pages
Global
From €5359EUR$5,835USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5359EUR$5,835USD£4,350GBP
- Report
- March 2022
- 518 Pages
Global
From €4927EUR$5,364USD£3,999GBP
- Report
- May 2022
- 100 Pages
Global
From €808EUR$850USD£679GBP
€1616EUR$1,700USD£1,358GBP
- Report
- October 2024
- 141 Pages
Poland
From €1711EUR$1,800USD£1,438GBP
- Report
- September 2023
- 234 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2024
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- December 2023
- 217 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- June 2023
- 235 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- April 2022
- 230 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- April 2022
- 120 Pages
Global
From €3660EUR$3,850USD£3,075GBP
- Report
- January 2022
- 100 Pages
Global
€3660EUR$3,850USD£3,075GBP
- Report
- December 2021
- 170 Pages
Global
€3660EUR$3,850USD£3,075GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more